Enjuvia is claimed to be the first and only plant-derived oral estrogen approved by FDA for the treatment of these specific symptoms associated with vaginal atrophy.
James Simon, clinical professor of obstetrics and gynecology at George Washington University, said: “Enjuvia has been shown in clinical studies to provide relief of moderate to severe vaginal dryness and pain with intercourse: symptoms of vulvar and vaginal atrophy associated with menopause. Enjuvia’s indication for the treatment of these moderate to severe vaginal symptoms associated with menopause affords women and healthcare professionals a new and effective treatment option for two of the most common symptoms associated with vaginal atrophy.”